Journal of Nutrition & Food Sciences

Journal of Nutrition & Food Sciences
Open Access

ISSN: 2155-9600

+32 25889658

Research Article - (2019) Volume 9, Issue 1

Does Active Nutritional Interventions Affect Adipokine Secretion in Hip Fracture Operated Elderly Patients?

Yochai Levy1, Ronit Anbar1,2, Avraham Weiss1, Tamar Koren Hakim1,2, Yulia Bugaevsky1, Adaya Nissenholtz1, Lisa Cooper1, Zecharia Madar3, Pierre Singer4 and Yichayaou Beloosesky1*
1Department of Geriatrics, Rabin Medical Center, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Israel
2Nutrition Unit, Rabin Medical Center, Petah Tikva, Israel
3The Robert H Smith Faculty of Agriculture, Food and Environmental Quality Sciences, School of Nutritional Sciences, Hebrew University, Jerusalem, Israel
4Department of General Intensive Care, Rabin Medical Center, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Israel
*Corresponding Author: Yichayaou Beloosesky, MD, Department of Geriatrics, Rabin Medical Center, Petah Tikva and Sackler School of Medicine, Tel Aviv University, 49100, Israel, Tel: 972 544560189

Abstract

Background: Adipokines such as ghrelin, leptin, resistin and adiponectin have been proposed as being involved in energetic balance and bone turnover. There is scarce knowledge as to adipokine activity in hip fractured elderly patients in acute settings. We evaluated whether active nutritional support may reflect on adipokines levels and affect outcomes.
Methods: A randomized controlled study measuring adipokine (ghrelin, leptin, resistin and adiponectin) levels in hip fractured geriatric patients receiving active nutritional support was conducted in the Ortho-Geriatric Unit Rabin Medical Center, Israel. The intervention group’s energy goal was calculated by repeated resting energy requirements whereas the control group received only standard nutritional support. Measurements were taken pre-operation, 48 h post-operative and on day 7 post-op.
Results: Ghrelin and adiponectin levels showed significant changes in both study groups with no significant change between groups. Ghrelin levels were also significantly higher on day 7 in patients without complications (p=0.035). Leptin levels differed between groups (p=0.038). In the intervention group, leptin levels decreased initially, then sharply increased, whereas the control group’s levels consistently decreased in all 3 measurements. Resistin levels did not change significantly over time.
Conclusion: Ghrelin and adiponectin may play a role in hip fractured patients irrespective of nutritional status whereas, ghrelin levels may also indicate post-operative complications. Leptin may be affected by energetic balance.

Keywords: Hip fracture; Adipokines; Nutritional support; Bone turnover

Background

Hip fractures are a significant health risk of the elderly population in western society and a major cause of morbidity and mortality. In the year 2000, approximately 1.6 million osteoporotic hip fractures occurred worldwide, their incidence and related morbidity is predicted to rise and reach 6.3 million by 2050 [1,2]. Hip fractures carry a significant mortality and morbidity burden with one-year mortality rates as high as 25% [3]. Many factors have been suggested which influence the prognosis of hip fractured patients, one of which is the patient’s nutritional status [4,5]. Approximately 50% of elderly hip fractured patients are malnourished on admission to the hospital and numerous others appear so after hospitalization. The deterioration of nutritional status of hospitalized patients can be partially attributed to an inflammatory response, catabolic status, poor intake, pain and medication adverse events. Negative effects of malnutrition include muscle wasting and weakness, impaired mobility, predisposition to decubitus ulcers, pulmonary complications (including atelectasis and pneumonia) and a predisposition to infections.

Evidence has shown a positive effect of active nutritional interventions in acute settings including hip fractured patients [6,7]. Recently, we demonstrated that nutritional support supervised by a dietician and guided by repeated measurements of resting energy requirements using indirect calorimetry, improved outcomes in geriatric patients following hip fracture surgery [8].

Adipokines such as ghrelin, leptin, resistin and adiponectin are cytokines secreted by the adipose tissue and have been suggested to play a role in the energy balance via dual effects on food intake and energy expenditure [9-14]. Ghrelin is an orexigenic protein considered an important gut-brain signal for appetite control and energy balance. By acting on vagal afferents or centrally, ghrelin can activate secretion of orexigenic peptides and inhibit anorexigenic hormones [13-16]. Leptin is the first adipokine documented. It is thought to play a role in the body’s energetic homeostasis and assist in maintaining body weight, mostly via hypothalamic receptors [17-19]. Leptin also appears to play a pro-inflammatory role in mediating an immune system response [20,21]. Resistin is a polypeptide secreted from rats’ adipose tissue and has been shown to play a role in the metabolic syndrome and insulin resistance [22]. However, in humans, resistin is primarily secreted by peripheral-blood mononuclear cells [23]. Data as to the role of human resistin levels and central/visceral obesity, as well as insulin resistance, is inconclusive. Resistin is considered an inflammatory mediator and a biomarker of cardiovascular (CV) diseases [24,25]. Adiponectin is the most abundant peptide secreted by adipocytes and plays a role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular disease [12]. Studies have advocated adiponectin to have anti-atherogenic and anti-inflammatory effects. In contrast to secretion of other adipokines, adiponectin paradoxically decreases in obesity [26-28].

Limited studies have reported on adipokine secretion and hip fractured elderly patients. Adiponectin but not leptin may increase fracture risk [29]. Admission low leptin levels in hip fractured patients have been found associated with increased post-op myocardial infarction risk [30] and predicted delirium [31]. Gulin et al found that high levels of adiponectin and leptin were associated with allcause one-year mortality [32]. Fisher et al reported that a high level of resistin was associated with cervical fracture, type 2 diabetes and history of stroke [33]. Our aim was to explore the impact of active nutritional interventions on adipokine (ghrelin, leptin, resistin and adiponectin) secretion in hip fractured operated elderly patients and their relationship to nutritional balance and clinical complications.

Methods

This randomized control study was conducted in the Ortho-geriatric Unit, Department of Geriatrics, Rabin Medical Center, Beilinson Hospital, Israel over a period of 20 months. The local institutional review board approved the study and written informed consent was obtained from all participants prior to randomization. Patients >65 years were included if they had been admitted to the unit within 48h after being diagnosed with a hip fracture, for whom orthopedic surgery was considered treatment of choice. Patients were excluded if they presented to the hospital more than 48h after the injury, were receiving steroids or immunosuppression therapy, had active oncologic disease, had suffered multiple fractures or had been diagnosed with dementia. Patients in need of supplemental oxygen were unable to complete the measurement of resting energy requirements (REE) and were thereby excluded.

Eligible patients were randomly assigned to 2 groups - a tight calorie (intervention) group and control group, within 48 h of the injury and prior to surgery; Randomization was performed using a concealed computer-generated program. All patients received standard preoperative care. The tight calorie group consumed calories with an energy goal determined by repeated REE measurements using indirect calorimetry (IC) (Fitmate, Cosmed, Italy), based on hospital-prepared diets (standard or texture-adapted). Oral nutritional supplements (ONS) were started 24 h after surgery. The amount was adjusted to make up the difference between energy received from hospital food and measured energy expenditure. The ONS provided were either Ensure Plus (Abbott Laboratories) containing 355 kcal/237 ml and 13.5 g protein or Glucerna (Abbott Laboratories) containing 237 kcal/237 ml and 9.9 g protein/237 ml. The patient, family and caregivers were taught the importance of nutritional support and how more attention should be given to personal food preferences. The control group received the usual hospital fare (standard or texture-adapted) and a fixed dose of ONS if one had already been prescribed prior to hospitalization. Hospital-prepared diets provide a mean of 1800 kcal and 80g of protein in the event that the meals are completely consumed by the patients.

All patients underwent IC measurements after fasting for at least 6 h during three time periods: on admission to the study, between 24 and 48 h following surgery and on the 7th day of the study. Measurements were performed by an experienced nurse or dietician. The device was automatically calibrated before each measurement and the REE recorded after 15 minutes. The nutrient intake of each patient was monitored by the research team on a daily basis. Twenty-four-hour food diaries were completed by the medical staff, family and/or caregivers. All meals had a known energy and protein content and the proportion of each component consumed was calculated using a food database program. In addition, the amount of ingested ONS was noted by the medical staff. Before surgery, grip strength in the dominant arm was measured with a hand-grip dynamometer (JAMAR®) with the highest of 3 measurements being recorded. Mid arm circumference (MAC, cm) was measured on the first day of the study using a non-stretchable flexible tape perpendicular to the long axis of the non-dominant arm.

Adiponectin, resistin, leptin and TNFα levels were measured using kits from R&D Systems, Minneapolis, MN, USA whilst ghrelin was measured according to a kit from the Millipore Corporation, Billerica, MA, USA. Blood samples for adipokines were taken on admission, 48 h post-op and on day 7 after enrollment. Routine lab tests including serum glucose, albumin, lymphocyte count and creatinine levels were also collected at these points. Blood was drawn during the early morning after the patient had fasted all night. Demographic, laboratory and clinical data were collected from the patients, caregivers and patient files. Body mass index measured body weight during hospitalization by seat scales, and height was calculated according to measured recumbent knee height. Nutritional status of the patient was assessed on the first day using the Mini Nutritional Assessment (MNA). Cumulative energy balance was assessed either on day 14 or upon discharge including the preoperative period. Comorbidity was assessed retrospectively with the Cumulative Illness Rating Scale for Geriatrics and the Charlson’s Comorbidity Index. The Functional Independence Measure scale was used to assess pre-facture functional ability and the Mini-Mental State Examination assessed cognitive function.

Complications included surgical (i.e., local bleeding or the need for repeat surgery); infectious, including pneumonia (based on clinical symptoms and signs and positive chest radiograph), urinary tract infection (based on clinical symptoms and signs and positive urinary cultures) and wound infections (based on clinical symptoms, signs and positive wound cultures); cardiovascular complications, such as myocardial infarction (based on clinical symptoms and signs together with a positive electrocardiogram and elevated enzymes) and congestive heart failure (based on clinical symptoms, signs and compatible chest radiograph); gastrointestinal (i.e., gastrointestinal bleeding); delirium lasting >4 days (based on the Confusion Assessment Method algorithm); deep vein thrombosis (based on clinical features and a positive doppler sonography examination) and the development of new pressure sores (stage 2 and above). Differences between the two groups were assessed using the Student’s t test for parametric data and the Chi-square test for categorical data. Changes in adipokine and cytokine levels over time were accessed using the repeated-measures analysis of variance test. The correlation of adipokines with mortality rates was verified using the Cox proportional-hazards model. All calculations were performed using SPSS software (version 12.0, SPSS, Chicago, IL). Results are expressed as mean standard deviation. A p level <0.05 was considered statistically significant.

Results

A total of 230 patients were screened, of whom 51 were found eligible for inclusion into the study. Reasons for non-inclusion included dementia (n=80), oncologic disease (n=17), presentation to hospital >48 h after the injury, (n=14), patients refusal to participate in the study (n=21) and others (n=47). A patient initially recruited to the study group did not undergo surgery and was therefore excluded. Thus, 50 patients were included; 22 in the intervention and 28 in the control group. All patients completed the study.

Baseline characteristics were published earlier [8] (Table 1) and did not significantly differ between groups. Mean age was 83 y, 35% males, cognitive, functional and comorbidity indexes were evaluated with no statistically significant difference found between the groups; 63.6% of the patients in the intervention group and 64.3% in the control group, were well nourished; 36.4% in the intervention group and 35.7% in the control group, were found at risk for malnutrition, differences were not statistically significant. Although, there were no malnourished patients in either group (i.e. MNA <17), 3 patients in the intervention group and 5 in the control group maintained MAC measurements

Variable Study Group (n=22) Control Group (n=28) p-value
Age (yrs) 82.27 ± 6.06 83.75 ± 6.43 0.876
Gender
Male n (%)
6 (27.3%) 11 (39.3%) 0.318
Female n (%) 16 (72.7%) 17 (60.7%)  
Weight (kg) 64.81 ± 9.52 64/29 ± 11/35 0.86
BMI (kg/m2) 25.18 ± 3.19 24.67 ± 4.42 0.653
Mean serum albumin (mg/dl) 3.23 ± 0.34 3.13 ± 0.27 0.282
Mean blood glucose (mg/dl) 121.54 ± 22.52 118.17 ± 21.09 0.589
MNA 24.84 ± 2.57 24.50 ± 2.97 0.672
CCI 0.81 ± 1.05 1.39 ± 1.13 0.073
CIRS-G 7.45 ± 3.59 7.39 ± 2.60 0.944
FIM 80.00 ± 17.62 79.1 ± 17.17 0.863
MMSE 25.16 ± 4.86 23.72 ± 5.19 0.375

Data are expressed as mean ± standard deviation.
Abbreviations: BMI, body mass index; MNA, Mini-Nutritional Assessment; CCI, Charlson's Comorbidity Index; CIRS-G, Cumulative Illness Rating Scale for Geriatrics; FIM,
Functional Independence Measure; MMSE, Mini-Mental State Examination.

Table 1: Baseline characteristics of study participants.

Table 2 summarizes the mean energy and protein values from recruitment prior to surgery and up to day 14. During the first 11 postoperative days (p=0.001), patients in the intervention group displayed a significantly higher mean daily intake of energy and protein compared to the control group Three patients in the control group received additional enteral energy sources: one patient required mechanical ventilation and was fed through a feeding tube while the other two had received ONS at home, on a regular basis, prior to the present admission and continued in the hospital. The length of the hospital stay, and the incidence of complications have been previously published and indicated a lower rate of complications, particular pneumonia, a significant negative correlation between the cumulative energy balance and total complication rate as well as the length of hospital stay in the intervention group [8].

Parameter Study group
(n=22)
Control group
(n=28)
P-value
Mean energy delivered/day (kcal/day) 1121.31 ± 299.05 777.09 ± 301.23 0.001
Mean ONS delivered energy/day (kcal/day) 220.33 ± 147.19 94.57 ± 233.82a 0.845
Mean protein delivered/day (g/day) 55.90 ± 18.14 37.41 ± 12.44 0.001
Mean daily energy balance (kcal) -176.90 ± 273.16 -490.67 ± 355.17 0.104
Cumulative energy balance (kcal) -1229.93 ± 1763 -4975.55 ± 4368 0.001

aIncluded 1 patient who required mechanical ventilation and received 1500kcal/day via tube-feeding. Data are expressed as mean ± standard deviation. REE, resting energy expenditure; kcal, kilocalories; ONS, oral nutritional supplements.

Table 2: Nutritional and energetic balance.

Adipokine kinetics are shown in Table 3. A significant elevation in ghrelin levels in both study groups (Figure 1) and significant changes in leptin levels between the groups (Figure 2) were found. In the intervention group, leptin initially declined and then sharply increased, whereas in the control group, it consistently slowly declined in all 3 measurements. We found no statistically significant differences between the groups on the third measurement of leptin. Resistin did not change significantly in either group (Figure 3). Adiponectin levels changed significantly (p=0.001) in both groups (Figure 4). Most of the change was attributed to a decline in adiponectin levels on day 3. There was no significant difference in adiponectin levels between the two groups. Ghrelin levels on day 7 were significantly higher in patients without complications compared to those with complications (p=0.035) which was primarily attributed to infections (urinary tract or pneumonia). We found no other correlations between adipokine levels, length of hospital stay or complications during the trial period.

  Study Group Control Group P value between groups
N Pre-Operation 48h Post Operation 7th day of the study N Pre-Operation 48h Post Operation 7th day of the study  
Ghrelin (pg/ml) 21 9 25 . 3 ± 373.5 1061.3 ± 570.2 1249.7 ± 691.6 27 919.5 ± 551 955.3 ± 607.4 1031.1 ± 685.9 N.S.a
Leptin (pg/ml) 22 16601 ± 9814 8291 ± 4812b 10801 ± 7511 27 15754 ± 11084 12 390 ± 10 08 1b 10123 ± 7990 N.S.
Resistin (ng/ml) 21 19.3 ± 7.8 19. 0 ± 7.87 19.2 ± 7.6 28 12.8 ± 3.9 14.3 ± 4.2 14.6 ± 5.3 N.S.
Adiponectin (μg/ml) 21 9127 ± 7 481 4050 ± 1993 5970 ± 2301 26 10736 ± 8711 6042 ± 4310 7601 ± 5149 N.S.c

aSignificant increase (p<0.04) in serum Ghrelin levels from day 1 to day 7 in both study and control groups.
bSignificant change between the study and control group after 48h (p=0.038).
cSignificant decrease (p<0.001) in serum adiponectin levels from day 1 to day 7 in both study and control groups.
N.S.- non significant

Table 3: Adipokine levels pre operation, 48 h post operation and on the 7th day.

nutrition-food-sciences-Ghrelin-change

Figure 1: Ghrelin change over time.

nutrition-food-sciences-Leptin-levels

Leptin change over time showing a significant decline and then increase in the study group (p=0.038).

Figure 2: Leptin levels between the groups.

nutrition-food-sciences-Resistin-change

Figure 3: Resistin change over time.

nutrition-food-sciences-Adiponectin-change

Figure 4: Adiponectin change over time.

Discussion

Overall, the adipokine kinetics levels did not significantly differ between the study groups. However, it seems that the adipokines ghrelin and leptin may be influenced from energetic balance. The elevation in ghrelin levels was also significantly lower for patients with complications during hospitalization. Adipokines are mediators secreted from the adipose tissue which plays a role in obesity, related morbidity and energetic homeostasis via autocrine and paracrine mechanisms. Ghrelin, other than its role in appetite control and energy balance may help regulate cardiovascular function, immune system and bone physiology [34-38]. Previous publication have demonstrated Ghrelin role in osteoblastic proliferation [36]. This may explain the elevation of Ghrelin in both study groups. Contrary to previous reports on rise of Ghrelin levels in states of negative energetic balance [35,39,40], we observed in the intervention group, an opposite trend toward a steeper ghrelin elevation. A possible explanation is that ghrelin may play a role in bone recovery, which was accelerated due to a lower energetic deficit in the study group compared to the control group. Ghrelin levels were significantly lower in patients with complications during hospitalization. These results are surprising considering that previous published studies report the elevation of ghrelin in states of systemic inflammation and in ICU patients [38,41]. Geriatric patients are known to exhibit a slower and lower response of the immune system to acute stress [42], although the nature of the complication, which was mostly mild, may not have been enough to induce ghrelin elevation.

Leptin involvement in bone homeostasis has been suggested in several previous studies with a negative feedback control of leptin on bone remodelling. A previous study by Di Monaco et al. of 74 women with osteoporotic hip fractures observed a negative correlation between leptin and bone density [43]. In a study of post hip fractured patients, osteocalcin, a marker for bone regeneration, was found to correlate with leptin [44]. Other studies have produced conflicting results as to the correlation between leptin and osteocalcin [45-47]. In our study, leptin levels in the intervention group at first declined, then sharply increased whereas, all 3 measurements in the control group the levels consistently slowly declined. Perhaps a lower acute inflammatory response in the intervention group may explain its primary decline but, in our study, we found no evidence to support this theory. These results may support the theory of leptin’s negative feedback on bone formation and resorption. The escalated elevation in the intervention group may suggest leptin’s role in the body’s energetic homeostasis.

A previous study of patients post hip fracture observed elevated resistin levels in cervical fractures [33]. A study of elderly patients post hip fracture, found that osteocalcin concentration is inversely associated with resistin [44]. The results of our study did not show a significant change in resistin levels in either of the study groups. Several studies reporting on animal models have suggested that adiponectin plays a role in bone homeostasis. Though, a previous study suggested that elevated levels of adiponectin correlate with a higher fracture risk in elderly men, its role in human bone homeostasis is still unclear [29]. We observed a significant decline in adiponectin levels on day 3 in both study groups. These finding may support the theory of adiponectin’s biphasic behavior in response to acute stress [47]. The short duration of the decline and the absence of change between the groups, suggests that adiponectin has no significant role in bone homeostasis or energetic balance in elderly patients post hip fracture.

The major limitation of this study is its short duration and relatively small sample base. The patients were not followed during their rehabilitation after hospital discharge. We hypothesis that the cytokine storm, shortly after a hip fracture operation [48], probably masked the changes of the adipokines secretion and the effect of the nutritional intervention. A longer follow-up might have confirmed the differences in adipokine secretions between groups. Another limitation is the relatively good nutritional status of the study participants, partially due to the exclusion criteria, i.e. active cancer and dementia which prevented many frail elderly patients from entering the trial. This, however, did not prevent most patients to be in a significant energetic deficit during the trial. We do not expect the results to change significantly in patients with poorer nutritional balance for whom the number of confounders will probably be higher due to a more significant morbidity.

Conclusion

In conclusion, we found no correlation between improved energy balance in geriatric hip fractured patients and adipokine levels. However, as noted, several changes in adipokine behaviors were observed. Differences may be the results of adipokine involvement in bone homeostasis and inflammatory states. A larger scale research study with a longer follow-up period is needed to expand our knowledge of these fascinating cytokines and their interactions with nutritional support.

Acknowledgement

The authors thank Mrs. Phyllis Curchack Kornspan for her editorial services.

References

  1. Bhandari M, Swiontkowski M (2017) Management of acute hip fracture. N Engl J Med 377: 2053-2062
  2. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, et al. (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22: 1277-1288
  3. Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51: 364-370
  4. Miu KYD, Lam PS (2017) Effects of Nutritional status on 6-month outcome of hip fractures in elderly patients. Ann Rehabil Med 41: 1005-1012
  5. van Wissen J, van Stijn MFM, Doodeman HJ, Houdijk APJ (2016) Mini nutritional assessment and mortality after hip fracture surgery in the elderly. J Nutr Health Aging 20: 964-968
  6. Eneroth M, Olsson U-B, Thorngren KG (2006) Nutritional supplementation decreases hip fracture-related complications. Clin Orthop Relat Res 451: 212-217
  7. Hoekstra JC, Goosen JHM, de Wolf GS, Verheyen CCPM (2011) Effectiveness of multidisciplinary nutritional care on nutritional intake, nutritional status and quality of life in patients with hip fractures: a controlled prospective cohort study. Clin Nutr 30: 455-461
  8. Anbar R, Beloosesky Y, Cohen J, Madar Z, Weiss A, et al. (2014) Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clin Nutr 33: 23-28
  9. Badman MK, Flier JS (2007) The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132: 2103-2115
  10. Vendrell J, Broch M, Vilarrasa N (2004) Resistin, Adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12: 962-971
  11. Henry BA, Clarke IJ (2008) Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol 20: 842-849
  12. Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50: 1511-1525
  13. Wang P, Mariman E, Renes J, Keijer J (2008) The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 216: 3-13
  14. Havel PJ (2004) Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53: S143-151
  15. De Vriese C, Perret J, Delporte C (2010) Focus on the short- and long-term effects of ghrelin on energy homeostasis. Nutrition 26: 579-584
  16. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612
  17. Edwards A, Abizaid A (2017) Clarifying the Ghrelin system’s ability to regulate feeding behaviours despite enigmatic spatial separation of the GHSR and its endogenous ligand. Int J Mol Sci 18: E859
  18. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, et al. (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252
  19. Perry B, Wang Y (2012) Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes 2: e26
  20. Jéquier E (2006) Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 967: 379-388
  21. Jacobsson S, Larsson P, Johansson G, Norberg M, Wadell G, et al. (2017) Leptin independently predicts development of sepsis and its outcome. J Inflamm 14: 19
  22. Marques MB, Langouche L (2013) Endocrine, metabolic, and Morphologic alterations of adipose tissue during critical illness. Crit Care Med 41: 317-325
  23. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312
  24. Park HK, Ahima RS (2013) Resistin in rodents and humans. Diabetes Metab J 37: 404-414
  25. Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, et al. (2007) Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 35: 1536-1542
  26. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, et al. (2005) Associations between Serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46: 379-380
  27. Ohashi K, Ouchi N, Matsuzawa Y (2012) Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94: 2137-2142
  28. Achari AE, Jain SK (2017) Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci 18: E1321
  29. Lisowska A, Tycinska A, Knapp M, Sawicki R, Lisowski P, et al. (2012) Adiponectin - An independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteries. Clin Chim Acta 413: 749-752
  30. Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, et al. (2011) Adipokines and the risk of fracture in older adults. J Bone Miner Res 26: 1568-1576
  31. Fisher AA, Goh SL, Srikusalankul W, Southcott EN, Davis MW (2009) Serum leptin levels in older patients with hip fracture--impact on peri-operative myocardial injury. Am Heart Hosp J 7: 9-16
  32. Chen XW, Shi JW, Yang PS, Wu ZQ (2014) Preoperative plasma leptin levels predict delirium in elderly patients after hip fracture surgery. Peptides 57: 31-35
  33. Gulin T, Kruljac I, Kirigin Biloš LS, Gulin M, Grgurević M, et al. (2017) The role of adipokines as prognostic factors of one-year mortality in hip fracture patients. Osteoporos Int 28: 2475-2483
  34. Fisher A, Southcott E, Li R, Srikusalanukul W, Davis M, et al. (2011) Serum resistin in older patients with hip fracture: Relationship with comorbidity and biochemical determinants of bone metabolism. Cytokine 56: 157-166
  35. Ukkola O (2005) Ghrelin and the metabolic balance. J Endocrinol Invest 28: 849-852
  36. Wang DH, Hu YS, Du JJ, Hu YY, Zhong WD, et al. (2009) Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway. Endocrine 35: 112-117
  37. Rodríguez-Pacheco F, Luque RM, Tena-Sempere M, Malagón MM, Castaño JP (2008) Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway. J Neuroendocrinol 20: 406-412
  38. Das UN (2011) Relationship between gut and sepsis: Role of ghrelin. World J Diabetes 2: 1-7
  39. Álvarez-Castro P, Pena L, Cordido F (2013) Ghrelin in obesity, physiological and pharmacological considerations. Mini Rev Med Chem 13: 541-552
  40. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346: 1623-1630
  41. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, et al. (2005) Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 62: 1-17
  42. Maruna P, Gürlich R, Frasko R, Rosicka M (2005) Ghrelin and leptin elevation in postoperative intra-abdominal sepsis. Eur Surg Res 37: 354-359
  43. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest 123: 958-965
  44. Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A (2003) Fat body mass, leptin and femur bone mineral density in hip-fractured women. J Endocrinol Invest 26: 1180-1185
  45. Fisher A, Srikusalanukul W, Davis M, Smith P (2012) Interactions between serum adipokines and osteocalcin in older patients with hip fracture. Int J Endocrinol 2012: 684323
  46. Berry PA, Jones SW, Cicuttini FM, Wluka AE, Maciewicz RA (2011) Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis Rheum 63: 700-707
  47. Flemming GM, Petzold S, Meigen C, Körner A, Kiess W, et al. (2012) Is circulating osteocalcin Related to adipokines and Overweight/obesity in children and adolescents? Exp Clin Endocrinol Diabetes 120: 383-387
  48. Beloosesky Y, Hendel D, Weiss A, Hershkovitz A, Grinblat J, et al. (2007) Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. J Gerontol A Biol Sci Med Sci 62: 420-426
Citation: Levy Y, Anbar R, Weiss A, Hakim TK, Bugaevsky Y, et al. (2019) Does Active Nutritional Interventions Affect Adipokine Secretion in Hip Fracture Operated Elderly Patients? J Nutr Food Sci 9: 747.

Copyright: © 2019 Levy Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top